| Thomas Bradley Dixon, PA | |
|
3200 Northline Ave, Ste 200, Greensboro, NC 27408-7616 | |
| (336) 545-5000 | |
| (336) 545-5020 |
| Full Name | Thomas Bradley Dixon |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 21 Years |
| Location | 3200 Northline Ave, Greensboro, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013985811 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 103827 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergeortho Pa | 0749188894 | 587 |
News Archive
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
AMRI announced today that a third compound being developed under its license and research agreement with Bristol-Myers Squibb Company will proceed into preclinical development. AMRI will receive a $750,000 payment from Bristol-Myers Squibb for the completion of this milestone, marking the fifth milestone payment in the ongoing research collaboration between the two companies.
The U.S. Department of Health and Human Services (HHS) today awarded more than $119 million to states and U.S. territories to support public health efforts to reduce obesity, increase physical activity, improve nutrition, and decrease smoking-the four most important actions for combating chronic diseases and promoting health
STENTYS S.A., which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today that it has begun the international APPOSITION III study of its self-apposing stent, with 50 patients already enrolled out of a total of 500. The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.
Achieving marital quality could seem daunting, even impossible to any couple, let alone a couple in which one of the partners is dealing with a serious illness. But a new study by Megan Robbins, psychology professor at the University of California, Riverside, may hold the answer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Bradley Dixon, PA Po Box 38008, Greensboro, NC 27438-8008 Ph: (336) 545-5000 | Thomas Bradley Dixon, PA 3200 Northline Ave, Ste 200, Greensboro, NC 27408-7616 Ph: (336) 545-5000 |
News Archive
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
AMRI announced today that a third compound being developed under its license and research agreement with Bristol-Myers Squibb Company will proceed into preclinical development. AMRI will receive a $750,000 payment from Bristol-Myers Squibb for the completion of this milestone, marking the fifth milestone payment in the ongoing research collaboration between the two companies.
The U.S. Department of Health and Human Services (HHS) today awarded more than $119 million to states and U.S. territories to support public health efforts to reduce obesity, increase physical activity, improve nutrition, and decrease smoking-the four most important actions for combating chronic diseases and promoting health
STENTYS S.A., which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today that it has begun the international APPOSITION III study of its self-apposing stent, with 50 patients already enrolled out of a total of 500. The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.
Achieving marital quality could seem daunting, even impossible to any couple, let alone a couple in which one of the partners is dealing with a serious illness. But a new study by Megan Robbins, psychology professor at the University of California, Riverside, may hold the answer.
› Verified 5 days ago
Ms. Heather Joy Laisure, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5701 W Friendly Ave, Greensboro, NC 27410 Phone: 336-852-1915 Fax: 336-294-3544 | |
Sara Heinz, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1002 N Church St Ste 102, Greensboro, NC 27401 Phone: 336-378-0713 | |
Emma Maureen Collins, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2105 Braxton Ln, Suite 101, Greensboro, NC 27408 Phone: 336-333-6306 Fax: 336-333-6309 | |
Irene Thomas Thayil, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Taylor Mackenzie Dale, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1313 Carolina St Ste 101, Greensboro, NC 27401 Phone: 336-275-0927 | |
Michael Carnaghi, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 1915 Lendew St, Greensboro, NC 27408 Phone: 336-275-3325 Fax: 336-275-5346 |